Website thumbnail FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes Related Blindness (1)
February 5, 2025

FDA Approves the First Anti-VEGF Port Delivery System for Diabetic Macular Edema

Got a patient with DME? Say goodbye to the monthly jab—Susvimo, the first continuous drug delivery system for DME just…

New Study Confirms AI’s Reliability in Home OCT Analysis for nAMD
February 4, 2025

New Study Demonstrates AI’s Reliability in Home OCT Analysis for nAMD 

Can AI finally match human experts in analyzing home OCT scans for nAMD? A new study says yes. Notal Vision…

Discover our fascinating content at issuu

explore